Biodesix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	26.28	43.09	32.71	62.13	5.29	5.91
Cash & Cash Equivalents	26.28	43.09	32.71	62.13	5.29	5.91
Cash Growth	-39.00%	31.72%	-47.35%	1075.29%	-10.62%	-
Receivables	7.68	5.07	3.66	15.3	5.29	1.89
Other Current Assets	5.72	5.18	7.25	8.71	2.12	2.11
Total Current Assets	39.68	53.33	43.61	86.14	12.7	9.91
Property, Plant & Equipment	29.61	8.82	4.18	3.18	2.12	1.39
Long-Term Investments	0	0	0	0	0	0.1
Goodwill and Intangibles	22.94	24.83	26.65	28.29	30.12	27.66
Other Long-Term Assets	6.86	5.92	1.66	3.46	0.09	0
Total Long-Term Assets	59.41	39.57	32.48	34.93	32.33	29.14
Total Assets	99.1	92.91	76.1	121.07	45.03	39.06
Accounts Payable	2.93	1.69	1.66	8.96	1.72	0.89
Deferred Revenue	0.32	0.96	1.85	3.53	1.28	0.49
Current Debt	0.3	1.59	0.02	11.84	12.16	0
Other Current Liabilities	29.86	18.6	25.43	7.79	7.44	3.09
Total Current Liabilities	33.42	22.84	28.96	32.13	22.6	4.47
Long-Term Debt	60.39	30.26	9.99	15.93	23.81	23.1
Other Long-Term Liabilities	0.71	19.2	17.42	31.85	29.8	25.56
Total Long-Term Liabilities	61.1	49.46	27.41	47.78	53.61	48.66
Total Liabilities	94.52	72.3	56.37	79.9	76.21	53.13
Total Debt	60.69	31.85	10.01	27.77	35.97	23.1
Debt Growth	90.55%	218.12%	-63.94%	-22.81%	55.73%	-
Retained Earnings	-419.57	-367.42	-301.97	-258.81	-227.46	-200.14
Shareholders' Equity	4.58	20.61	19.73	41.17	-225.14	-198.03
Net Cash / Debt	-34.41	11.24	22.7	34.36	-30.69	-17.19
Net Cash / Debt Growth	-	-50.49%	-33.93%	-	-	-
Net Cash Per Share	-0.42	0.27	0.83	7.10	-126.80	-85.92
Working Capital	6.27	30.5	14.65	54.02	-9.9	5.45
Book Value Per Share	0.06	0.49	0.72	8.51	-930.33	-990.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).